User profiles for author:"Stenson K." OR author:" K. Stenson"
Kevin StensonProfessor of Physics, University of Colorado Boulder Verified email at colorado.edu Cited by 247738 |
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection
KM Stenson, DJ Haraf, H Pelzer… - … –Head & Neck …, 2000 - jamanetwork.com
Objectives To evaluate the necessity, technical feasibility, and complication rate of neck
dissection performed on patients with head and neck cancer after 5 cycles of concomitant …
dissection performed on patients with head and neck cancer after 5 cycles of concomitant …
Experimental Evidence for a Light and Broad Scalar Resonance in Decay
From a sample of 1172±61 D+→ π− π+ π+ decays, we find Γ (D+→ π− π+ π+)/Γ (D+→ K−
π+ π+)= 0.0311±0.0018− 0.0026+ 0.0016. Using a coherent amplitude analysis to fit the …
π+ π+)= 0.0311±0.0018− 0.0026+ 0.0016. Using a coherent amplitude analysis to fit the …
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
…, F Rosen, WM Stadler, W Recant, K Stenson… - Journal of clinical …, 2003 - ascopubs.org
Purpose: The epidermal growth factor receptor (EGFR) is a mediator of squamous cell
carcinoma of the head and neck (SCCHN) development. ZD1839 is an orally active …
carcinoma of the head and neck (SCCHN) development. ZD1839 is an orally active …
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas
…, A Langerman, L Portugal, E Blair, K Stenson… - Clinical cancer …, 2015 - AACR
Purpose: The genetic differences between human papilloma virus (HPV)–positive and–
negative head and neck squamous cell carcinomas (HNSCC) remain largely unknown. To …
negative head and neck squamous cell carcinomas (HNSCC) remain largely unknown. To …
[HTML][HTML] Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year …
B Brockstein, DJ Haraf, AW Rademaker, MS Kies… - Annals of oncology, 2004 - Elsevier
Background: Locoregionally advanced, stage IV head and neck cancer has traditionally
carried a poor prognosis. We sought to assess changes in patterns of failure, prognostic …
carried a poor prognosis. We sought to assess changes in patterns of failure, prognostic …
Dalitz Plot Analysis of the Decay and Indication <?format ?>of a Low-Mass Scalar Resonance
…, CJS Salinas, NR Stanton, RJ Stefanski, K Stenson… - Physical Review Letters, 2002 - APS
We study the Dalitz plot of the decay D+→ K-π+ π+ with a sample of 15090 events from
Fermilab experiment E791. Modeling the decay amplitude as the coherent sum of known K …
Fermilab experiment E791. Modeling the decay amplitude as the coherent sum of known K …
[HTML][HTML] Editor's choice–the implications of non-compliance to endovascular aneurysm repair surveillance: a systematic review and meta-analysis
Objective/background Increasingly, reports show that compliance rates with endovascular
aneurysm repair (EVAR) surveillance are often suboptimal. The aim of this study was to …
aneurysm repair (EVAR) surveillance are often suboptimal. The aim of this study was to …
Study of the Decay and Measurement of Masses and Widths
From a sample of 848±44 D s+→ π− π+ π+ decays, we find Γ (D s+→ π− π+ π+)/Γ (D s+→ φ
π+)= 0.245±0.028− 0.012+ 0.019. Using a Dalitz plot analysis of this three body decay, we …
π+)= 0.245±0.028− 0.012+ 0.019. Using a Dalitz plot analysis of this three body decay, we …
B physics at the Tevatron: Run II and beyond
…, T Skwarnicki, A Smith, B Speakman, K Stenson… - arXiv preprint hep-ph …, 2002 - arxiv.org
This report provides a comprehensive overview of the prospects for B physics at the
Tevatron. The work was carried out during a series of workshops starting in September …
Tevatron. The work was carried out during a series of workshops starting in September …
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study
…, W Liu, C Pierce, JE Dancey, K Stenson… - The lancet …, 2009 - thelancet.com
Background Epidermal growth factor receptor (EGFR) is a validated target in squamous-cell
carcinoma of the head and neck, but in patients with recurrent or metastatic disease, EGFR …
carcinoma of the head and neck, but in patients with recurrent or metastatic disease, EGFR …